Carly Bess Scalise (Carly Bess Williams, Carly B Scalise)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Metastatic Breast Cancer

Ejection Fraction

Immune Response

Peritoneal Dialysis

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer medicine

Molecular cancer therapeutics

Breast cancer research and treatment

Vanderbilt University

Georgia College and State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Aug 01 2019

United States

Postdoctoral Trainee :: Pharmacology

Medical University of South Carolina

United States

Pre-Doctoral Student :: Cell and Molecular Pharmacology & Experimental Therapeutics

Education History

Georgia College and State University

United States

BSC :: Biology

Publications

Rebecca C Arend, Carly Bess Scalise, Emily R Gordon, Allison M Davis, McKenzie E Foxall, Bobbi E Johnston, David K Crossman, Sara J Cooper
Metabolic Alterations and WNT Signaling Impact Immune Response in HGSOC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Rebecca C Arend, Carly Bess Scalise, Jhalak Dholakia, Maahum Z Kamal, Haley B Thigpen, David Crossman, Warner K Huh, Charles A Leath
Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer. Cancer medicine 10 (22) (2021)
Nidhi Goel, McKenzie E Foxall, Carly Bess Scalise, Jaclyn A Wall, Rebecca C Arend
Strategies in Overcoming Homologous Recombination Proficiency and PARP Inhibitor Resistance. Molecular cancer therapeutics 20 (9) (2021)
Carly Bess Scalise, Caroline A Nebhan, Jinming Yang, Lauren S Starnes, Chi Yan, Anna E Vilgelm, Sheau-Chiann Chen, Gregory Dan Ayers, Vandana Abramson, Ingrid A Mayer, Ann Richmond
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. Breast cancer research and treatment 184 (2) (2020)